Pharmaceutical Intermediates Bag-In-Box (BIB) Packaging
Clean-process flexible containment systems engineered for the aseptic storage, transport, and dispensing of pharmaceutical intermediates, active pharmaceutical ingredient (API) precursor solutions, buffers, and process liquids in drug manufacturing and bioprocessing operations. All product-contact materials meet USP Class VI biocompatibility standards and are manufactured under cGMP protocols.
Core Advantages
All product-contact film layers undergo USP Class VI biological reactivity testing, ensuring no cytotoxic, systemic toxicity, or intracutaneous reactivity effects. Film formulations are free of plasticizers, latex, and animal-derived components for pharmaceutical process compatibility.
Clean-PE and fluorinated barrier films undergo extractables profiling per USP 1663 and leachables assessment per USP 1664. Documentation packages include comprehensive extractables data for regulatory submissions and process validation requirements.
Bags are manufactured and filled in ISO Class 7 cleanroom environments with validated sterilization protocols. Double-bagging options with outer protective overwrap are available for high-potency API intermediates requiring enhanced containment.
Each BIB unit is serialized with batch traceability from film extrusion through final packaging. Documentation packages include certificates of conformance, sterilization validation records, and change control notification commitments for regulatory filing support.
Product Specifications & Quality Standards
Application Scenarios
Quality Assurance & Handling Protocols
BIB suppliers for pharmaceutical applications should undergo on-site quality audits per ICH Q7 GMP guidelines for active pharmaceutical ingredients. Audit scope includes resin sourcing, cleanroom manufacturing practices, sterilization validation, and change control procedures.
Conduct product-specific extractables studies using actual pharmaceutical intermediate formulations at worst-case temperature and time conditions. Study design should follow USP 1663 guidelines with analytical methods capable of detecting organic and inorganic extractables at ppb levels.
Validate the BIB filling process with media fill simulations per FDA aseptic processing guidance. Demonstrate sterility assurance level of 10⁻⁶ for terminally sterilized bags. For aseptically filled products, validate environmental monitoring program for ISO Class 7 filling suite.
Include BIB-packaged intermediates in ICH Q1A stability studies. Monitor package integrity, extractables migration over time, and container-closure integrity at each stability time point. Use dye ingress or helium leak testing for container-closure integrity verification.
Regulatory & Technical Inquiries
Standard documentation package includes: USP Class VI certification for all product-contact materials, extractables profile report per USP 1663, Certificate of Conformance for each production lot, sterilization validation records, resin and additive traceability statements, and change control commitment letter. Drug Master File (DMF) Type III filing with FDA is available for select BIB products upon request.
Container-closure integrity testing (CCIT) should follow USP 1207 guidelines. Recommended methods include helium leak detection for high-sensitivity applications or vacuum decay testing for routine quality control. BIB bags with aseptic connectors can achieve helium leak rates below 1.5×10⁻⁶ mbar·L/sec, meeting sterile barrier requirements for liquid pharmaceutical products.
Standard Clean-PE films are compatible with aqueous and polar solvent mixtures up to 30% organic content. For intermediates containing higher concentrations of organic solvents such as methanol, ethanol, acetone, or DMSO, fluorinated PE or PTFE-lined film constructions are required. Always conduct a 30-day solvent compatibility study under expected storage conditions before commercial implementation.
Gamma irradiation at 25–40 kGy is the standard sterilization method for pharma-grade BIB bags. Electron beam processing is available for heat-sensitive film formulations. Ethylene oxide (EtO) sterilization is not recommended due to residual gas concerns. Autoclave sterilization at 121°C is compatible with select high-temperature film grades; verify maximum temperature rating with the bag supplier before autoclave processing.



